Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic intervention
about
Structural insights into conformational stability of both wild-type and mutant EZH2 receptorOrchestration of H3K27 methylation: mechanisms and therapeutic implication.The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia.Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery.Screening for histone codebreakers
P2860
Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic intervention
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Gain-of-function mutation of c ...... y for therapeutic intervention
@ast
Gain-of-function mutation of c ...... y for therapeutic intervention
@en
Gain-of-function mutation of c ...... y for therapeutic intervention
@nl
type
label
Gain-of-function mutation of c ...... y for therapeutic intervention
@ast
Gain-of-function mutation of c ...... y for therapeutic intervention
@en
Gain-of-function mutation of c ...... y for therapeutic intervention
@nl
prefLabel
Gain-of-function mutation of c ...... y for therapeutic intervention
@ast
Gain-of-function mutation of c ...... y for therapeutic intervention
@en
Gain-of-function mutation of c ...... y for therapeutic intervention
@nl
P2860
P3181
P1476
Gain-of-function mutation of c ...... y for therapeutic intervention
@en
P2093
Christopher R. Vakoc
P2860
P3181
P356
10.1097/CCO.0000000000000151
P407
P577
2015-01-01T00:00:00Z